Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 14, 2006
Six-month results are consistent with ARRIVE I data
-
Mar 12, 2006
Complex insulin-treated diabetic population shows numerical trend toward improved MACE outcomes with TAXUS versus Cypher
-
Mar 12, 2006
TAXUS trials continue to deliver positive outcomes in complex cases
-
Mar 10, 2006
Team will lead CRM Group following acquisition of Guidant
-
Mar 8, 2006
Completes Company's application for FDA approval
-
Mar 7, 2006Results highlight efficacy of TAXUS in most complex lesions and highest risk patients
Results highlight efficacy of TAXUS in most complex lesions and highest risk patients
-
Mar 3, 2006
A live webcast and replay of the March 9 conference session will be available
-
Mar 2, 2006
Shareholders of both companies to vote on March 31, 2006
-
Mar 1, 2006
A live webcast and replay of the March 7 conference session will be available
-
Feb 15, 2006
(February 15, 2006) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received reimbursement approval from the French government for its TAXUS